Abstract
Atrial fibrillation (AF) is a multifaceted and highly variable disease that is often difficult to manage within the traditional health-care model. The conventional model of regular or pre-scheduled appointments with physicians or allied health professionals is poorly suited to the unpredictable and often urgent clinical needs of patients with AF. Mobile health (mHealth) has the potential to dramatically transform the delivery and quality of AF care. In this brief review, we summarize the current limitations and evidence gaps in treating patients with AF. We then describe the current mHealth landscape, changes in telehealth coverage and reimbursement, and recent technological advances of smartphones, mobile applications, and connected wearable devices. We also describe important barriers and challenges, such as clinical management of large volumes of data, application of predictive analytics/machine learning, and the need for high-quality randomized clinical trials.
Similar content being viewed by others
References
Turakhia MP, Hoang DD, Xu X, Frayne S, Schmitt S, Yang F, et al. Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: the Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study. Am Heart J. 2013;165(1):93–101. e101.
Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, et al. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration. Am Heart J. 2014;167(6):810–7.
Shore S, Ho PM, Lambert-Kerzner A, Glorioso TJ, Carey EP, Cunningham F, et al. Site-level variation in and practices associated with dabigatran adherence. JAMA. 2015;313(14):1443–50.
Turakhia MP, Ullal AJ. US health care policy and reform: implications for cardiac electrophysiology. J Interv Card Electrophysiol. 2013;36(2):129–36.
Pew Research Center, April, 2015, The smartphone difference. http://www.pewinternet.org/2015/04/01/us-smartphone-use-in-2015/.
Fox, S. (February 1, 2011). Pew Research Center’s Internet & American life project—health topics. http://pewinternet.org/Reports/2011/HealthTopics.aspx.
Carol E. Torgan, P. D. (November 6, 2009.). The mHealth summit: local & global converge. http://caroltorgan.com/mhealth-summit/.
Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–63.
Digital health funding: 2015 year in review. http://rockhealth.com/reports/digital-health-funding-2015-year-in-review/.
Geneva Healthcare. Revolutionizing cardiac device data management. http://www.genevahealthcare.com/. Accessed February 2, 2016.
Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol. 2011;58(17):1741–9.
Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112(4):520–4.
Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95 e11–97.
Qardio—state of the heart technology. https://www.getqardio.com/. Accessed March 10, 2016.
AliveCor love your heart. http://www.alivecor.com/. Accessed March 9, 2016.
Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, et al. Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol. 2015;116(5):733–9.
Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015). Mass screening for untreated atrial fibrillation: The STROKESTOP Study. Circulation, doi:10.1161/CIRCULATIONAHA.114.014343.
Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167–76.
Chyou, J. Y., Hunter, T. D., Mollenkopf, S. A., Turakhia, M. P., & Reynolds, M. R. (2015). Individual and combined risk factors for incident atrial fibrillation and incident stroke: an analysis of 3 million at-risk US patients. J Am Heart Assoc, 4(7), doi:10.1161/JAHA.114.001723.
Steven R. Steinhubl, M., Rajesh R. Mehta, R., Gail S. Ebner, B., Marissa M. Ballesteros, B., MBA, MPH, Waalena, J., Gregory Steinberg, M., BCh, et al. (2016). Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: the mHealth screening to prevent strokes (mSToPS) trial. American Heart Journal.
Turakhia MP, Ullal AJ, Hoang DD, Than CT, Miller JD, Friday KJ, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF). Clin Cardiol. 2015;38(5):285–92.
Passman, R., Leong-Sit, P., Andrei, A. C., Huskin, A., Tomson, T. T., Bernstein, R., et al. (2015). Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study. J Cardiovasc Electrophysiol, doi:10.1111/jce.12864.
Turakhia, M. P., & Estes, N. A., 3rd (2015). Stroke risk stratification in atrial fibrillation: bridging the evidence gaps. J Cardiovasc Electrophysiol, doi:10.1111/jce.12891.
Keach JW, Bradley SM, Turakhia MP, Maddox TM. Early detection of occult atrial fibrillation and stroke prevention. Heart. 2015;101(14):1097–102.
McManus DD, Lee J, Maitas O, Esa N, Pidikiti R, Carlucci A, et al. A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation. Heart Rhythm. 2013;10(3):315–9.
Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, et al. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med. 2014;174(2):186–93.
Patel N, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Effectiveness of atrial fibrillation monitor characteristics to predict severity of symptoms of atrial fibrillation. Am J Cardiol. 2014;113(10):1674–8.
Lowes, R. (December 17, 2014). EHR meaningful use penalty will hit 257,000 clinicians in 2015. http://www.medscape.com/viewarticle/836824.
Hodge Jr JG, Weidenaar K, Baker-White A, Barraza L, Bauerly BC, Corbett A, et al. Legal innovations to advance a culture of health. J Law Med Ethics. 2015;43(4):904–12.
Revisor of Statutes, S. o. M. (2015). 62A.672 Coverage of telemedicine services. https://www.revisor.leg.state.mn.us/statutes/?id=62A.672.
Basu S, Phillips RS, Bitton A, Song Z, Landon BE. Medicare chronic care management payments and financial returns to primary care practices: a modeling study. Ann Intern Med. 2015;163(8):580–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None
Disclaimer
The content and opinions expressed are solely the responsibility of the authors and do not necessarily represent the views or policies of the Department of Veterans Affairs.
Rights and permissions
About this article
Cite this article
Turakhia, M.P., Kaiser, D.W. Transforming the care of atrial fibrillation with mobile health. J Interv Card Electrophysiol 47, 45–50 (2016). https://doi.org/10.1007/s10840-016-0136-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-016-0136-3